Newsletter Archive

41. 06.04.25 -- Take-Home Microdosing Trial Studies Sub-Hallucinogenic For Depression 6/4/2025
    06/04/25 Clinical Leader Newsletter
42. 06.04.25 -- STREAM Edition: What's Most Important When It Comes To Risk Management Of Data Flow And Governance? 6/4/2025

    06/04/25 Clinical Leader Newsletter

43. 06.03.25 -- How AI And Secondary Data Use Are Changing The Way We Do CTAs, Part Two 6/3/2025
    06/03/25 Clinical Leader Newsletter
44. 06.03.25 -- Understanding Patient Decision-Making To Drive Enrollment & Retention 6/3/2025

    06/03/25 Clinical Leader Newsletter

45. 06.02.25 -- Are Sites Even Using AI?: How Sponsors And CROs Can Support Uptake 6/2/2025
    06/02/25 Clinical Leader Newsletter
46. 06.02.25 -- Changes To The Global Clinical Trial Landscape 6/2/2025

    06/02/25 Clinical Leader Newsletter

47. 05.30.25 -- What's The Risk Of Letting Researchers Use LLMs? 5/30/2025
    05/30/25 Clinical Leader Newsletter
48. 05.30.25 -- Make Your Clinical Trial Process More Efficient With Software And Services 5/30/2025
    05/30/25 Clinical Leader Newsletter
49. 05.29.25 -- How Close Is The First FDA-Approved Full-Spectrum Botanical Drug For Autism? 5/29/2025
    05/29/25 Clinical Leader Newsletter
50. 05.29.25 -- Overcoming The Challenges Of Legacy ERP Systems 5/29/2025

    05/29/25 Clinical Leader Newsletter